Trustar Capital
Overview
Trustar Capital is a private equity firm and an affiliate of CITIC Capital Holdings Limited that focuses on control buyout opportunities in companies capitalizing on the growth and productivity of the Chinese economy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neolix | Oct 2026 | Series E | Co-investor |
| AlphaPai | Sep 2026 | Series B | Co-investor |
| Deep Intelligent Pharma | Feb 2026 | VC Round | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Trustar Capital based?
Trustar Capital is headquartered in Hong Kong, Hong Kong.
When was Trustar Capital founded?
Trustar Capital was founded in 2002.
How many portfolio companies does Trustar Capital have?
Trustar Capital has 12 portfolio companies in Caplight's dataset.
What are some companies in Trustar Capital's portfolio?
Recent investments visible on Caplight include Neolix, AlphaPai, AlphaPai, Deep Intelligent Pharma, Neolix.
What was Trustar Capital's most recent investment?
Trustar Capital's most recent investment on Caplight was in Neolix in 2026.
What sectors does Trustar Capital focus on?
Trustar Capital focuses on Consumer & Commerce, Consumer & Commerce, Consumer & Commerce, FinTech, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Energy & Sustainability, Frontier & Industrial Tech, Consumer & Commerce, Healthcare & Life Sciences, FinTech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, Media, Entertainment & Gaming, Frontier & Industrial Tech, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Energy & Sustainability.
What company stages does Trustar Capital focus on?
Trustar Capital typically invests at the MultiStage stage.
What is Trustar Capital's AUM?
Trustar Capital's assets under management are estimated between $9.3B and $9.6B.